Correlation Between Adaptimmune Therapeutics and VBI Vaccines

Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and VBI Vaccines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and VBI Vaccines into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and VBI Vaccines, you can compare the effects of market volatilities on Adaptimmune Therapeutics and VBI Vaccines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of VBI Vaccines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and VBI Vaccines.

Diversification Opportunities for Adaptimmune Therapeutics and VBI Vaccines

-0.26

Correlation Coefficient

Adaptimmune Therapeutics  VBI Vaccines

Very good diversification

The 3 months correlation between Adaptimmune and VBI is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and VBI Vaccines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VBI Vaccines and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with VBI Vaccines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VBI Vaccines has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and VBI Vaccines go up and down completely randomly.

Pair Corralation between Adaptimmune Therapeutics and VBI Vaccines

Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to generate 1.17 times more return on investment than VBI Vaccines. However, Adaptimmune Therapeutics is 1.17 times more volatile than VBI Vaccines. It trades about 0.12 of its potential returns per unit of risk. VBI Vaccines is currently generating about 0.03 per unit of risk. If you would invest  59.00  in Adaptimmune Therapeutics Plc on February 4, 2024 and sell it today you would earn a total of  60.00  from holding Adaptimmune Therapeutics Plc or generate 101.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Adaptimmune Therapeutics Plc  vs.  VBI Vaccines

Adaptimmune Therapeutics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Adaptimmune Therapeutics Plc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Adaptimmune Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

VBI Vaccines

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days VBI Vaccines has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable forward indicators, VBI Vaccines is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Adaptimmune Therapeutics and VBI Vaccines

The main advantage of trading using opposite Adaptimmune Therapeutics and VBI Vaccines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, VBI Vaccines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VBI Vaccines will offset losses from the drop in VBI Vaccines' long position.

The idea behind Adaptimmune Therapeutics Plc and VBI Vaccines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.